Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits
- PMID: 3464957
- PMCID: PMC386930
- DOI: 10.1073/pnas.83.21.8370
Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits
Abstract
Through the use of a quantitative solution hybridization assay with 32P-labeled cDNA probes, we found that mevinolin, an inhibitor of cholesterol synthesis, elevates the level of mRNA for the low density lipoprotein receptor in livers of hamsters and rabbits. In hamsters the maximal effect (3-fold increase) occurred at 0.1% mevinolin in the diet for 10 days. The same dose produced a maximal induction (10-fold) of mRNA levels for 3-hydroxy-3-methylglutaryl CoA reductase, the rate-limiting enzyme of cholesterol synthesis, and a maximal decrease (80%) in plasma cholesterol. The drug lowered the level of all cholesterol-carrying lipoproteins in plasma. In normal rabbits, mevinolin produced a 90% reduction in plasma low density lipoprotein-cholesterol levels, which was associated with a 2.5-fold increase in low density lipoprotein receptor mRNA levels. A similar induction of receptor mRNA occurred in livers of Watanabe-heritable hyperlipidemic rabbits, although the plasma cholesterol was not reduced to normal, presumably because the receptors produced by the mutant mRNA function poorly. These data are consistent with the hypothesis that mevinolin and other inhibitors of 3-hydroxy-3-methylglutaryl CoA reductase lower plasma cholesterol levels in part by stimulating production of mRNA for the low density lipoprotein receptor in liver.
Similar articles
-
Regulation of hepatic receptor-dependent degradation of LDL by mevinolin in rabbits with hypercholesterolemia induced by a wheat starch-casein diet.Biochim Biophys Acta. 1983 Nov 29;754(2):134-41. doi: 10.1016/0005-2760(83)90154-6. Biochim Biophys Acta. 1983. PMID: 6317039
-
Induction of mRNA for low-density lipoprotein receptors in heterozygous Watanabe heritable hyperlipidemic rabbits treated with CS-514 (Pravastatin) and cholestyramine.Circulation. 1989 May;79(5):1084-90. doi: 10.1161/01.cir.79.5.1084. Circulation. 1989. PMID: 2496935
-
Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.J Clin Invest. 1980 Nov;66(5):1094-100. doi: 10.1172/JCI109938. J Clin Invest. 1980. PMID: 6903572 Free PMC article.
-
Regulation of plasma cholesterol by compactin and mevinolin.Nutr Rev. 1985 Sep;43(9):266-8. doi: 10.1111/j.1753-4887.1985.tb02445.x. Nutr Rev. 1985. PMID: 3903562 Review. No abstract available.
-
Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.Eur J Clin Pharmacol. 1991;40 Suppl 1:S11-4. Eur J Clin Pharmacol. 1991. PMID: 2044637 Review.
Cited by
-
Development of a Microminipig Model of Atherosclerosis for the Evaluation of a HMGCR Inhibitor.In Vivo. 2024 Jan-Feb;38(1):98-106. doi: 10.21873/invivo.13415. In Vivo. 2024. PMID: 38148058 Free PMC article.
-
Clinical application of somatic gene therapy in inborn errors of metabolism.J Inherit Metab Dis. 1990;13(4):597-616. doi: 10.1007/BF01799515. J Inherit Metab Dis. 1990. PMID: 2122123
-
Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions.J Clin Invest. 1988 Mar;81(3):909-17. doi: 10.1172/JCI113402. J Clin Invest. 1988. PMID: 3343347 Free PMC article.
-
Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver.Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):935-8. doi: 10.1073/pnas.92.4.935. Proc Natl Acad Sci U S A. 1995. PMID: 7862668 Free PMC article.
-
Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding.Lipids. 1995 Jul;30(7):607-17. doi: 10.1007/BF02536997. Lipids. 1995. PMID: 7564915
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical